BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31691205)

  • 1. "Lower abdominal pains, as if I was being squeezed…in a clamp": A Qualitative Analysis of Symptoms, Patient-Perceived Side Effects and Impacts of Ovarian Cancer.
    Martin ML; Halling K; Eek D; Reaney M
    Patient; 2020 Apr; 13(2):189-200. PubMed ID: 31691205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings.
    Galipeau N; Klooster B; Krohe M; Tang DH; Revicki DA; Cella D
    J Patient Rep Outcomes; 2019 Feb; 3(1):10. PubMed ID: 30734110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talking About Breast Cancer: Which Symptoms and Treatment Side Effects are Important to Patients with Advanced Disease?
    Niklasson A; Paty J; Rydén A
    Patient; 2017 Dec; 10(6):719-727. PubMed ID: 28432593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms and Functional Limitations in the First Year Following a Myocardial Infarction: A Qualitative Study.
    Gwaltney C; Reaney M; Krohe M; Martin MM; Falvey H; Mollon P
    Patient; 2017 Apr; 10(2):225-235. PubMed ID: 27637486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a disease conceptual model of patient experience with metastatic colorectal cancer: identification of the most salient symptoms and impacts.
    Guillemin I; Darpelly M; Wong B; Ingelgård A; Griebsch I
    J Cancer Surviv; 2024 Jun; 18(3):761-771. PubMed ID: 36515691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
    Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
    Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of symptoms described by ovarian cancer survivors.
    Stavraka C; Ford A; Ghaem-Maghami S; Crook T; Agarwal R; Gabra H; Blagden S
    Gynecol Oncol; 2012 Apr; 125(1):59-64. PubMed ID: 22155797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study.
    Jackson K; Parthan A; Lauher-Charest M; Broderick L; Law N; Barnett C
    Neurol Ther; 2023 Feb; 12(1):107-128. PubMed ID: 36322146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician Interviews.
    Holmstrom S; Naidoo S; Turnbull J; Hawryluk E; Paty J; Morlock R
    Patient; 2019 Feb; 12(1):57-67. PubMed ID: 30519830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum.
    Frey MK; Ellis AE; Koontz LM; Shyne S; Klingenberg B; Fields JC; Chern JY; Blank SV
    Gynecol Oncol; 2017 Aug; 146(2):386-391. PubMed ID: 28602549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
    King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
    Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "What doesn't kill you makes you stronger": an ovarian cancer survivor survey.
    Stewart DE; Wong F; Duff S; Melancon CH; Cheung AM
    Gynecol Oncol; 2001 Dec; 83(3):537-42. PubMed ID: 11733968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.
    Lim AW; Mesher D; Gentry-Maharaj A; Balogun N; Jacobs I; Menon U; Sasieni P
    J Natl Cancer Inst; 2012 Jan; 104(2):114-24. PubMed ID: 22247022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom Assessment in Patients with Advanced Cancer: Are the Most Severe Symptoms the Most Bothersome?
    Li B; Mah K; Swami N; Pope A; Hannon B; Lo C; Rodin G; Le LW; Zimmermann C
    J Palliat Med; 2019 Oct; 22(10):1252-1259. PubMed ID: 31063024
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials.
    Donovan KA; Donovan HS; Cella D; Gaines ME; Penson RT; Plaxe SC; von Gruenigen VE; Bruner DW; Reeve BB; Wenzel L
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25006190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding polycystic ovary syndrome from the patient perspective: a concept elicitation patient interview study.
    Martin ML; Halling K; Eek D; Krohe M; Paty J
    Health Qual Life Outcomes; 2017 Aug; 15(1):162. PubMed ID: 28821294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Content validity of the NCCN-FACT ovarian symptom index-18 (NFOSI-18).
    Jensen SE; Kaiser K; Lacson L; Schink J; Cella D
    Gynecol Oncol; 2015 Feb; 136(2):317-22. PubMed ID: 25499602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatigue in the healthy and in cancer patients. II. A qualitative study for conceptual analysis].
    Glaus A; Crow R; Hammond S
    Pflege; 1999 Apr; 12(2):75-81. PubMed ID: 10437551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.
    Webber K; Carolus E; Mileshkin L; Sommeijer D; McAlpine J; Bladgen S; Coleman RL; Herzog TJ; Sehouli J; Nasser S; Inci G; Friedlander M
    Gynecol Oncol; 2019 Oct; 155(1):126-134. PubMed ID: 31416612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.